ArticleScientific reports2016

LTP-1, a novel antimitotic agent and Stat3 inhibitor, inhibits human pancreatic carcinomas in vitro and in vivo.

Han-Li Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.